Introduction

• Alberto Andrighetto

Organizational aspects

• Stefano Corradetti

Work Package 1: activities and prospects

• Devid Maniglio
• Valerio Di Marco

Work Package 2: activities and prospects

• Marcello Lunardon

The ISOLPHARM beamline at SPES

• Davide Serafini

Work Package 3: activities and prospects

• Matteo Negrini

Work Package 4: activities and prospects

• Silva Bortolussi

Characterization of 111Ag radiation against prostate cancer cells

• Francesca Rana

111Ag-emitted radiation as a targeted breast-cancer therapeutic approach

• Cristiana Alberghina

SPES_MED status

• Emilio Mariotti

Future plans for ISOLPHARM

• Alberto Arzenton

Thoughts on possible European Project Proposals

• Nicola Belcari

Discussion on new projects

• Alberto Arzenton
• Alberto Andrighetto

Chelation of 111Ag: new perspectives

• Marianna Tosato